Aas-S200 Cadmium Nephrotoxicity Test Urine & Blood for Kidney Patients

Product Description

🔬 Technology Overview

The trace element analyzer is designed to measure lead (Pb) and cadmium (Cd) levels in whole blood, breast milk, or urine.

It employs atomic absorption spectrometry (AAS), using a graphite tube as a high-temperature atomizer, combined with self-absorption background correction technology to ensure accurate and reliable results.

📋 Product Specifications

Trace Element Analyzer AAS-S200

This device enables simultaneous detection of lead and cadmium. It consists of a light source system, graphite furnace atomization system, optical system, and an integrated processing system.

In addition, it can be connected to an automatic autosampler for automated sample loading. When used in combination with dedicated reagents, the system allows for in vitro detection with high precision and efficiency.

Sample Types: Whole blood, serum, urine, breast milk.

Applications:

  • Screen for elevated lead and cadmium levels
  • Assess heavy metal exposure risk
  • Monitor blood lead levels in children
AAS-S200 Analyzer
Detection Process
Sample Analysis
Laboratory Testing
⚙️ Technical Parameters
Technical Chart
Model AAS-S200
Detection Method Atomic spectrometry
Elements Detected Lead (Pb), Cadmium (Cd)
Detection Time 1.5 minutes per sample
Scope of Application Determine trace element levels in the human body with matched testing reagents
Detection Limit Pb ≤ 4 pg
Detection Deviation ≤ 10%
Dimension 782 mm × 560 mm × 338 mm
Operating Temperature 10°C - 30°C
Operating Humidity ≤ 70%
Key Features
  • Broad Application: Supports measurement of multiple specimen types including whole blood, urine, and breast milk.
  • Rapid Detection: Simultaneous quantification of lead and cadmium in a single sample within just 1.5 minutes.
  • Easy Operation: Integrated design; when used with dedicated reagents and an optional automatic autosampler, the system streamlines workflow.
  • Enhanced Safety: Continuous monitoring of graphite furnace status with precise process control and self-absorption background correction technology.
🏢 Professional Capabilities
Facility Overview

Founded in 2001, our group has evolved into a high-tech biomedical enterprise that integrates R&D, production, sales, and after-sales service. With an extensive integrated R&D center, the company is listed on the Shenzhen Stock Exchange ChiNext.

R&D Center

R&D Excellence

Boasting strong independent R&D capabilities, we have established professional teams for molecular diagnosis, immunoassay, and mass spectrometry. Our trace element detection systems are used in thousands of hospitals globally.

Mass Spectrometry

Advanced Innovation

Our fully automated nucleic acid detection products, based on microfluidic technology, are recognized as "laboratory on a chip." We focus on high-end mass spectrometry analysis within the life sciences sector.

Frequently Asked Questions
Q: What types of samples can be tested with the AAS-S200?
A: The system is versatile and can analyze whole blood, serum, urine, and breast milk samples.
Q: How long does it take to get results for lead and cadmium?
A: The analyzer provides simultaneous quantification for both elements in approximately 1.5 minutes per sample.
Q: Does the equipment require manual sample loading?
A: While it has an integrated manual processing system, it can be optionally equipped with an automatic autosampler for fully automated sample loading.
Q: What is the primary technology used for detection?
A: It uses Atomic Absorption Spectrometry (AAS) with a graphite furnace atomizer and self-absorption background correction for high precision.
Q: What is the monthly production capacity for this equipment?
A: The factory has a production capacity of approximately 2,000 units per month, ensuring steady supply.
Q: Are the products currently in stock for quick shipping?
A: Yes, standard products are typically in stock and can be shipped within 7 days of order confirmation.

Related Products